Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological Comparison of Buprenorphine and Methadone
NCT00000334Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Dec 2002
- Primary completion
- Nov 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in opioid use disorder (OUD), opioid withdrawal, sponsored by National Institute on Drug Abuse. Started Dec 2002; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)opioid withdrawal
Beyond the preview
Go deeper on NCT00000334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000334.